The Need for a Multidisciplinary Approach for Successful High-Risk Pulmonary Embolism TreatmentApril 8, 2025
FDA Approves Pluvicto for Earlier Use in PSMA-Positive Metastatic Castration-Resistant Prostate CancerApril 1, 2025Oncology
Do Patients With Intermediate-Risk Cervical Cancer Need Adjuvant Chemotherapy?March 24, 2025Genitourinary Cancer
Can Adjuvant Immunotherapy Boost Survival Outcomes in Advanced Nasopharyngeal Cancer?March 24, 2025Head & Neck/Thyroid Cancers
